Life Settlements for Trustees: Fiduciary Considerations

Trust-Owned Life Insurance: A Fiduciary Asset Like Any Other

Trillions of dollars of life insurance face value sits inside trusts — irrevocable life insurance trusts (ILITs) built for estate liquidity, revocable trusts that swept in policies during funding, special needs trusts, credit shelter trusts holding survivorship coverage. However it arrived, once a policy is trust property the trustee holds it subject to the same duties that govern every other trust asset: prudence, loyalty, impartiality among beneficiaries, and the affirmative duty to monitor.

That last duty is where trustees stumble. The Uniform Prudent Investor Act, adopted in some form in nearly every state, requires trustees to evaluate assets in the context of the whole portfolio and to review them on an ongoing basis — not to file the policy in a drawer and forward Crummey notices once a year. A universal life policy is not a static asset. Its internal cost of insurance rises with the insured’s age, its crediting rates may have underperformed the original illustration for decades, and it can be quietly consuming itself toward a lapse the trustee will learn about from a carrier’s final notice.

The monitoring baseline is straightforward: obtain an in-force illustration from the carrier at least every year or two, showing whether current funding carries the policy to maturity; track the insured’s health and the trust’s premium funding source; and confirm the policy’s original purpose still exists. The right to sell the policy if it no longer serves — grounded in Grigsby v. Russell (1911), which established policies as ordinary transferable property — is a tool every trustee should know is in the box. For the transaction basics, see what is a life settlement.

The Triggers: When a Trust Policy Becomes a Settlement Candidate

Certain fact patterns recur so reliably that trustees should treat them as standing triggers for a market valuation.

• The estate tax purpose evaporated. Many ILITs were funded when the federal exemption was a fraction of today’s figure. Post-TCJA, the exemption exceeds $13 million per individual, and a policy bought to pay an estate tax the family will never owe is a solution without a problem. The trust may serve beneficiaries better holding cash or investments than a death benefit no one needs.
• The grantor stopped gifting premiums. ILIT premiums typically depend on annual gifts. When the grantor tires of writing checks, loses capacity, divorces, or dies (on a survivorship policy insuring the survivor), the funding stream ends and the policy starts consuming its own cash value toward lapse.
• The policy is underperforming. Illustrations from the 1990s assumed crediting rates that never materialized; the trustee’s annual in-force illustration shows a policy that will die before the insured does without sharply higher premiums.
• Beneficiary needs changed. Beneficiaries need funds now — education, health, housing — and unanimously prefer present value to a distant death benefit.
• Business purposes ended. Buy-sell or key-person coverage in trust outlived the sale of the company.

In each case the fiduciary question is identical: does holding this policy remain prudent, and if not, which exit realizes the most value? The screening criteria are the standard ones — insured generally 65+, face value generally $100,000+, permanent coverage (or convertible term) in force two-plus years — detailed at who qualifies for a life settlement.

Lapse and Surrender: The Two Decisions That Generate Trustee Litigation

Trustee liability around life insurance clusters at two decision points, both of which are avoidable with process.

The silent lapse. A trustee who lets a policy lapse — misses the funding problem, misses the grace period of 30–31 days, or affirmatively decides to stop premiums without valuing the asset — has arguably destroyed trust property. If that policy would have commanded a settlement offer, the measure of the beneficiaries’ claim is not abstract: it is the market value the trustee failed to realize. Courts applying prudent investor standards have shown little patience for “we didn’t know it could be sold” as a defense, particularly from professional and corporate trustees who are charged with knowing the tools of their trade.

The untested surrender. Surrendering to the carrier feels safe — a definite check, a closed file. But the GAO’s study of the settlement market found sellers received roughly four to eight times surrender value. A trustee who surrenders a qualifying policy for $30,000 when the market would have paid $140,000 has a $110,000 problem if beneficiaries later ask whether alternatives were considered. The comparison itself is cheap: obtaining settlement market indications costs the trust nothing and either confirms surrender was right or reveals it was not. The analytical framework is laid out in life settlement vs. surrender.

The defensive posture is the same for both: before any policy is allowed to terminate for any reason, obtain and file (1) the current in-force illustration, (2) the carrier’s surrender quote, and (3) a settlement market valuation or documented explanation of why the policy could not qualify. Three documents convert a future lawsuit into a closed question.

Trustee Decision Point	Prudent-Process Step	Document for the Trust File	Risk if Skipped
Annual policy monitoring	Order in-force illustration; review funding adequacy	Illustration + review memo	Silent lapse; failure-to-monitor claim
Purpose review	Confirm original trust purpose (e.g., estate tax) still exists	Purpose analysis memo	Holding a pointless asset; impartiality claims
Considering termination	Obtain surrender quote AND settlement market valuation	Both quotes side by side	Surrendering at a fraction of market value
Authority to sell	Review trust instrument; obtain consents/NJSA/court order as needed	Instrument excerpts + consents	Ultra vires sale; personal liability
Sale execution	Licensed parties, competitive bids, compensation disclosure, escrow	License verifications, all bids, closing statement	Underpricing; process-failure claims
Post-sale	Reinvest per prudent investor standards; report to beneficiaries	Closing memorandum to beneficiaries	Surprise-driven disputes years later

ILIT-Specific Issues: Powers, Grantors, and Crummey Mechanics

Irrevocable life insurance trusts add governance wrinkles that a trustee must clear before signing a settlement contract.

Confirm the power to sell. Most modern ILIT instruments grant broad powers over policies — to hold, exchange, surrender, or sell. Older or narrowly drafted instruments may not, and a few affirmatively restrict disposition. Read the document; where authority is unclear, obtain beneficiary consents, a nonjudicial settlement agreement where state law allows, or court instruction. Selling without authority is worse than not selling.

Mind the grantor’s role — and keep the trustee’s independence. The grantor often initiates the conversation (“stop asking me for premium gifts”), but the trustee’s duty runs to the beneficiaries, not the grantor. A trustee who sells simply because the grantor wants out, without independent analysis of the beneficiaries’ interests, has confused whose fiduciary they are. Document the beneficiary-centered reasoning separately from the grantor’s preferences.

Proceeds change the trust’s character. A settlement converts a death-benefit asset into investable cash inside the trust. That raises follow-on prudent investor questions — allocation, distribution provisions, whether the trust should terminate early under its terms or state small-trust statutes — that should be mapped before closing, not after.

Alternatives inside the ILIT toolbox. Before selling, a diligent ILIT trustee prices the alternatives: reduced paid-up status, a 1035 exchange into a lower-cost or guaranteed policy, distribution of the policy to beneficiaries where permitted, or the grantor’s family purchasing the policy from the trust at market value. The full duty framework for these trusts — notices, funding, monitoring — is covered in the ILIT trustee duties guide.

Tax Treatment of a Trust’s Policy Sale

The income tax framework is the same three-tier structure that applies to individual sellers, but who reports it depends on the trust’s tax status.

The three tiers. Under IRS Revenue Ruling 2009-13 as modified by the 2017 Tax Cuts and Jobs Act: proceeds up to the policy’s basis (premiums paid) are recovered tax-free; the layer from basis to cash surrender value is ordinary income; the excess over surrender value is capital gain. Reconstructing basis on a decades-old trust policy — premiums funded by years of grantor gifts — is a real project; start pulling premium histories from the carrier early.

Grantor vs. non-grantor status. Most ILITs are grantor trusts during the grantor’s life, meaning the sale’s income lands on the grantor’s personal return even though the trust receives the cash — a result the grantor should hear about before the trustee signs, not at filing time. Non-grantor trusts report the income themselves, where compressed fiduciary brackets reach the top rates at very low income levels, making the character split between ordinary income and capital gain more consequential.

Transfer-for-value awareness. Settlements are sales for value; the buyer takes the policy subject to transfer-for-value rules that are the buyer’s problem, but trustees restructuring policies among related parties before a sale should get counsel to avoid creating avoidable tax on the eventual death benefit.

Viatical treatment under IRC 101(g), which can make proceeds tax-free when the insured is terminally ill with a life expectancy under 24 months, is built around sales by the insured; whether and how it interacts with a trust’s sale requires specific professional advice. The general framework, with worked examples, is at the life settlement tax treatment guide.

Running a Defensible Sale Process

For a trustee, the sale process is inseparable from the liability shield: every step below produces a document for the trust file.

• Verify authority and paper it. Trust instrument provisions, beneficiary consents or NJSA, or court order, as the situation requires. Providers will ask for the trust document and trustee certification.
• Assemble the underwriting file. In-force illustration, premium history, policy contract, and the insured’s HIPAA authorizations for medical records. Two independent life expectancy reports (typically 2–6 weeks) will anchor pricing.
• Deal only with licensed parties. Most states license settlement providers and brokers under statutes modeled on the NAIC Life Settlements Model Act; New Jersey’s regime is enforced by the Department of Banking and Insurance. Verify licenses directly with the regulator and file the confirmation.
• Create genuine competition. Multiple providers bidding is both the price maximizer and the core of the prudence record. Keep every written offer, including the ones declined.
• Obtain full compensation disclosure. Broker commissions in dollars, gross versus net offers — required disclosures under Model Act-based laws, and exhibits for the file.
• Close through escrow. Independent escrow holds funds until the carrier confirms the ownership change; the statutory rescission window (15–30 days depending on state) runs after closing.
• Maintain premiums to the closing date. A lapse mid-process forfeits every offer.
• Report to beneficiaries. A closing memorandum summarizing the rationale, process, bids, and net result — circulated to beneficiaries — turns the transaction from a discovery surprise into old news.

Expect 60 to 120 days from engagement to funded escrow, plus whatever governance steps the trust requires up front.

Worked Example: An Underfunded ILIT Finds Its Exit

A composite illustration. In 1999, a grantor established an ILIT holding a $2 million survivorship policy, built to pay estate taxes for an estate then projected at $6 million against a sub-$1 million exemption. Twenty-six years later the exemption exceeds $13 million per person, the projected estate tax is zero, the surviving grantor is 88, and annual gifts of $38,000 fund premiums for a benefit the family no longer needs. The grantor tells the corporate trustee she is done gifting.

The trustee runs the process rather than the reflex. The in-force illustration shows the policy lapsing in four years without gifts. The carrier quotes a $95,000 surrender value. The trust instrument grants express power to sell policies; the three adult beneficiaries sign consents acknowledging the analysis. The trustee engages a licensed broker, verifies licensure with the state, and the file — anchored by two life expectancy reports on the 88-year-old insured — draws bids from four providers over three rounds, topping out at $520,000, comfortably inside the typical 10–35%-of-face range and more than five times surrender.

Tax counsel confirms grantor-trust status, so the grantor reports the income under the three-tier rules; basis from decades of premiums shelters a large share. Funds land in escrow, the carrier confirms transfer, the rescission window passes, and the trust reinvests $520,000 under its distribution provisions — with two beneficiaries taking educational distributions the following year. The closing memorandum runs six pages. No beneficiary will ever have to ask whether the trustee tested the market, because the answer is in the file. That is what the process is for: not just a better price, but an unimpeachable record.

---

Frequently Asked Questions

Can a trustee sell a life insurance policy owned by a trust?

Generally yes, when the trust instrument grants power over policies — most modern instruments authorize holding, exchanging, surrendering, or selling them — and the sale serves the beneficiaries’ interests. Where the document is silent or restrictive, trustees obtain beneficiary consents, a nonjudicial settlement agreement, or court instruction first. Settlement providers will require the trust document and trustee certification. The underlying property right is settled law: Grigsby v. Russell established life insurance as ordinary transferable property over a century ago.

Is a trustee liable for letting a trust-owned life insurance policy lapse?

Exposure is real. Prudent investor standards require trustees to monitor trust assets, and a lapsed policy that would have commanded a life settlement offer gives beneficiaries a concrete damages theory — the market value the trustee failed to realize, which the GAO found runs roughly four to eight times surrender value for qualifying policies. Professional trustees are held to what tools of the trade they should have known. Annual in-force illustrations and a documented valuation before any policy terminates are the standard protections.

Should an ILIT trustee surrender or sell a policy the grantor stopped funding?

Neither, until both numbers are on the table. When premium gifts stop, the trustee should order an in-force illustration to see how long the policy survives, get the carrier’s surrender quote, and obtain settlement market indications — then compare, alongside alternatives like reduced paid-up status or a 1035 exchange. Settlements typically pay several times surrender value for qualifying policies, but the trustee’s duty is to the analysis, not to any particular outcome, and the comparison itself becomes the liability shield.

Who pays the taxes when an ILIT sells a policy in a life settlement?

It depends on the trust’s income tax status. Most ILITs are grantor trusts during the grantor’s life, so the sale’s income — computed under the IRS three-tier rules (tax-free basis recovery, ordinary income up to surrender value, capital gain above) — lands on the grantor’s personal return even though the trust keeps the cash. Non-grantor trusts report the income themselves under compressed fiduciary brackets. Brief the grantor and tax counsel before closing so no one meets the result at filing time.

What is a trust-owned life insurance (TOLI) audit and do I need one?

A TOLI audit is a structured review of every policy a trust holds: carrier strength, in-force performance versus original illustrations, funding adequacy, purpose alignment, and disposition options including the settlement market. Corporate trustees run them on a cycle; individual trustees — often family members who inherited the role — usually have never done one, which is precisely why they should. An audit that surfaces an underperforming or purposeless policy early gives the trustee time to exchange, restructure, or sell it deliberately.

Does the estate tax exemption increase mean ILITs should sell their policies?

Not automatically — it means the analysis must be redone. With the federal exemption above $13 million per individual, many ILITs hold coverage for an estate tax the family will never owe, which weakens the case for continued premium funding. But state estate taxes reach lower, exemptions can change with legislation, and a policy may still serve liquidity or legacy goals. The trustee’s job is a documented purpose review; a sale is one possible conclusion, not a foregone one.

How does a trustee prove a life settlement price was fair to beneficiaries?

Through competition and paper. Engage licensed providers or a licensed broker, verify every license with the state insurance department, and generate multiple written bids over successive rounds — the bid history itself demonstrates the market was tested. Obtain written disclosure of all broker compensation in dollars, close through independent escrow, and circulate a closing memorandum to beneficiaries summarizing rationale, process, offers received, and net proceeds. A trustee with that file has converted a potential dispute into a documented, answered question.

What happens to the money after a trust sells a life insurance policy?

The proceeds are trust property, governed by the same instrument that governed the policy. The trustee reinvests them under prudent investor standards, makes distributions as the document directs, or — where the trust’s purpose has ended and state law or the instrument permits — moves toward modification or termination, sometimes through beneficiary agreement or small-trust statutes. Mapping the post-sale plan before closing is best practice, because converting a death benefit into investable cash changes the trust’s character and the beneficiaries’ expectations.

Related Reading

• Ilit Trustee Duties Guide
• Life Settlement Guide Executors
• Life Settlement Vs Surrender
• What Is A Life Settlement

---

Pine Lake Life Solutions does not purchase life insurance policies and does not provide legal, tax, or investment advice. Information provided is for educational purposes only. Eligibility for any option, including life settlements, is not guaranteed and depends on individual circumstances, policy terms, underwriting, and market conditions. Consult independent legal, tax, or financial professionals before making decisions regarding a life insurance policy.